Abstract: The present disclosure relates to substituted hydroxystilbene compounds and derivatives, specifically 2-substituted hydroxystilbene compounds and derivatives, the synthesis of such compounds and their use in therapy.
Type:
Application
Filed:
December 23, 2020
Publication date:
May 25, 2023
Applicant:
Kynan Duke IP, LLC
Inventors:
Colin Charles Duke, Rujee Kyokajee DUKE, Van Hoan TRAN
Abstract: A compound, composition, or method for treating cancer is disclosed. The compound (that can be used in the composition and/or method) can include or pharmaceutically acceptable salts or solvates thereof. R1a-R1d, R2-R3 (and R4 where applicable), and A---B can be as defined herein.
Type:
Application
Filed:
May 26, 2022
Publication date:
December 1, 2022
Applicant:
Kynan Duke IP, LLC
Inventors:
Colin Charles Duke, Van Hoan TRAN, Rujee Kyokajee DUKE
Abstract: A compound, composition, or method for treating cancer is disclosed. The compound (that can be used in the composition and/or method) can include or pharmaceutically acceptable salts or solvates thereof. R1a-R1d, R2-R3 (and R4 where applicable), and A---B can be as defined herein.
Type:
Grant
Filed:
June 30, 2020
Date of Patent:
June 7, 2022
Assignee:
KYNAN DUKE IP, LLC
Inventors:
Colin Charles Duke, Van Hoan Tran, Rujee Kyokajee Duke
Abstract: The present disclosure is drawn to methods of treating diseases or disorders, and uses of preparing medicaments. The methods of administering and/or preparation of medicaments can include the use of a compound of Formula (I) disclosed herein, or a geometric isomer, stereoisomer, and/or pharmaceutically acceptable salt or solvate thereof.
Type:
Grant
Filed:
December 16, 2020
Date of Patent:
May 17, 2022
Assignee:
Kynan Duke IP, LLC
Inventors:
Colin Charles Duke, Rujee Kyokajee Duke, Van Hoan Tran